Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Efstathios Kastritis

1-50 of 247 results

View this query on the Wikidata Query Service
BET bromodomain inhibition as a therapeutic strategy to target c-Myc

scientific article (publication date: 16 September 2011)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

scientific article
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

scientific article published in December 2005
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

scientific article published on August 2016
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

scientific article published on 22 October 2012
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

scientific article published on 9 August 2008
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis

scientific article published on 19 January 2010
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).

scientific article published on 19 February 2009
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

scientific article
European Myeloma Network guidelines for the management of multiple myeloma-related complications

scientific article
Diagnosis of monoclonal gammopathy of renal significance

scientific article
Pathogenesis and treatment of renal failure in multiple myeloma

scientific article
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia

scientific article published on December 2008
Hematological findings and complications of COVID-19

scientific article published on 13 April 2020
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies

scientific article published on 26 August 2010
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

scientific article
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents

scientific article published on 01 April 2007
Treatment options for relapsed and refractory multiple myeloma

scientific article published on 02 April 2015
VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA s

scientific article
Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

scientific article
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy

scientific article published on 21 December 2011
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).

scientific article published on 4 September 2013
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis

scientific article
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

scientific article published on 6 November 2012
How I treat monoclonal gammopathy of renal significance (MGRS).

scientific article published on 09 October 2013
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

scientific article
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

scientific article
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.

scientific article
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

scientific article published on 18 July 2016
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

scientific article
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy

scientific article published on 6 April 2012
Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma

scientific article published on 20 December 2008
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents

scientific article published on 26 May 2010
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group

scientific article published on June 2004
Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor–κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

scientific article published on 01 January 2007
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

article by Efstathios Kastritis et al published 18 April 2012 in Blood
Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study

article
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens

scientific article published on May 2008
The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma

scientific article published on 31 July 2014
Treatment of light chain deposition disease with bortezomib and dexamethasone

scientific article
Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication

scientific article
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group

scientific article
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents

The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy

scientific article published in February 2005
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin

scientific article published on June 2005
Recent advances in the management of AL Amyloidosis

scientific article published on October 22, 2015
Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.

scientific article
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)

scientific article

Paulina is supported by:

About Paulina

Help